PubRank

Moon Seok Choi

Author PubWeight™ 76.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol 2005 1.79
2 Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2006 1.79
3 Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005 1.66
4 Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005 1.57
5 [Changes in the profiles of causative agents and antibiotic resistance rate for spontaneous bacterial peritonitis: an analysis of cultured microorganisms in recent 12 years]. Korean J Hepatol 2007 1.54
6 Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol 2012 1.47
7 Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 2012 1.47
8 [Clinical features and predictive factors of acute hepatitis A complicated with acute kidney injury]. Korean J Gastroenterol 2010 1.41
9 Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005 1.39
10 Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy. Chest 2005 1.25
11 Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006 1.24
12 [The age-specific seroprevalence of hepatitis A virus antibody in Korea]. Korean J Hepatol 2007 1.15
13 Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response. J Gastroenterol Hepatol 2010 1.12
14 Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol 2011 1.07
15 Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity. Am J Clin Oncol 2010 1.06
16 Disease progression and the risk factor analysis for chronic hepatitis C. Liver Int 2008 1.02
17 Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011 1.00
18 Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma. Radiother Oncol 2009 0.99
19 Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures. World J Gastroenterol 2012 0.99
20 Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int 2012 0.97
21 A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B. Hepatol Int 2011 0.95
22 Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Gastroenterol 2006 0.95
23 [Peginterferon alfa-2a plus ribavirin for initial treatment of chronic hepatitis C in Korea]. Korean J Hepatol 2006 0.94
24 HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol 2014 0.94
25 Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. J Clin Gastroenterol 2008 0.92
26 The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma. Liver Int 2014 0.92
27 Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma. Cancer Chemother Pharmacol 2004 0.92
28 Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroenterol Hepatol 2014 0.92
29 Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock. Abdom Imaging 2015 0.92
30 The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities. Am J Clin Oncol 2013 0.90
31 Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients. J Gastroenterol Hepatol 2012 0.89
32 Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma. Korean J Hepatol 2010 0.89
33 Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study. Hepatogastroenterology 2008 0.88
34 Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liver Int 2013 0.88
35 Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol 2011 0.86
36 Fungal polyketide synthase product chain-length control by partnering thiohydrolase. ACS Chem Biol 2014 0.85
37 Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma. Liver Int 2013 0.85
38 Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area. Clin Mol Hepatol 2012 0.84
39 Seroprevalence of anti-HAV among patients with chronic viral liver disease. World J Gastroenterol 2011 0.84
40 Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 2006 0.84
41 Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea. J Gastroenterol Hepatol 2011 0.84
42 A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease. Clin Mol Hepatol 2012 0.84
43 The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Hepatogastroenterology 2009 0.83
44 Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study. Dig Dis Sci 2012 0.83
45 Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2010 0.83
46 Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 2006 0.83
47 [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma]. Korean J Hepatol 2006 0.82
48 The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma. Medicine (Baltimore) 2016 0.82
49 Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation. Gut Liver 2009 0.82
50 Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. Transplantation 2013 0.82
51 Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma. World J Gastroenterol 2012 0.81
52 Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. Digestion 2015 0.81
53 [Early diagnosis and improved survival with screening for hepatocellular carcinoma]. Taehan Kan Hakhoe Chi 2003 0.81
54 A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine-resistant chronic hepatitis B. Gut Liver 2010 0.81
55 [Natural history of gastric varices and risk factors for bleeding]. Korean J Hepatol 2008 0.81
56 [Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma]. Korean J Hepatol 2004 0.81
57 Virological response to adefovir monotherapy and the risk of adefovir resistance. World J Gastroenterol 2011 0.80
58 Gastrointestinal complications after radiation therapy in patients with hepatocellular carcinoma. Hepatogastroenterology 2005 0.79
59 An iterative, bimodular nonribosomal peptide synthetase that converts anthranilate and tryptophan into tetracyclic asperlicins. Chem Biol 2013 0.79
60 The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in Korea. Gut Liver 2011 0.79
61 Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. J Korean Med Sci 2005 0.79
62 Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels. World J Gastroenterol 2013 0.79
63 Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation. Scand J Gastroenterol 2013 0.78
64 Analysis of the core gene of hepatitis B virus in Korean patients. Liver Int 2007 0.78
65 Long-term treatment outcomes for autoimmune hepatitis in Korea. J Korean Med Sci 2009 0.78
66 [Mesenchymal hamartoma of the liver in adults]. Taehan Kan Hakhoe Chi 2003 0.77
67 Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas. Hepatogastroenterology 2015 0.77
68 [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease]. Korean J Hepatol 2005 0.77
69 Older donor allografts are associated with poor patient survival after living donor liver transplantation for hepatitis B virus-related liver diseases. Liver Int 2007 0.77
70 New automated synthesis of [18F]FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report. Nucl Med Biol 2011 0.77
71 [The clinical usefulness of SPIO-MRI in detection and staging of hepatocellular carcinoma]. Taehan Kan Hakhoe Chi 2003 0.76
72 High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: assessment with liver computed tomography. World J Gastroenterol 2012 0.76
73 Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection. Hepatogastroenterology 2014 0.76
74 Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study. Medicine (Baltimore) 2016 0.75
75 Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinoma. Gut Liver 2011 0.75
76 The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma. Hepatogastroenterology 2009 0.75
77 A case of nonalcoholic steatohepatitis and small intestinal bacterial overgrowth with peripheral edema caused by intestinal bypass surgery and relieved by repair. Gut Liver 2012 0.75
78 Pegylated interferon and ribavirin in the retreatment of chronic hepatitis C in Korea. Gut Liver 2013 0.75
79 Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients. Gut Liver 2011 0.75
80 An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study. Medicine (Baltimore) 2016 0.75
81 Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance. J Gastroenterol Hepatol 2012 0.75
82 [Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease]. Korean J Hepatol 2005 0.75
83 Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1. Hepatogastroenterology 2013 0.75
84 [Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients]. Korean J Hepatol 2009 0.75
85 [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding]. Taehan Kan Hakhoe Chi 2002 0.75
86 Ribavirin dose and treatment outcome of Korean patients with genotype 1 chronic hepatitis C. Hepatogastroenterology 2012 0.75
87 [Clinical features of surgically resected focal nodular hyperplasia of the liver]. Korean J Hepatol 2004 0.75
88 [A case of hepatic angiomyolipoma mimicking hepatocellular carcinoma]. Korean J Gastroenterol 2008 0.75
89 [The Assessment of Korean Gastroenterology Research Achievements]. Korean J Gastroenterol 2009 0.75
90 [Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation]. Korean J Hepatol 2009 0.75
91 Defining virologic relapse in chronic hepatitis B. Dig Dis Sci 2011 0.75
92 [Prevalence and risk factors of significant intrapulmonary shunt in cirrhotic patients awaiting liver transplantation]. Taehan Kan Hakhoe Chi 2002 0.75
93 Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinoma. Dig Dis Sci 2012 0.75
94 Photodynamic therapy for bile duct invasion of hepatocellular carcinoma. Photochem Photobiol Sci 2013 0.75